JuliaAChapmanMD
Obstetrics & Gynecology • Lenexa, KSGynecologic Oncology, Urogynecology & Pelvic Reconstructive Surgery
Associate Professor, Obstetrics and Gynecology, University Kansas School of Medicine
Dr. Chapman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
10600 Quivera
Lenexa, KS 66215Phone+1 913-219-7150- Is this information wrong?
Education & Training
University of California (Irvine)Residency, Obstetrics and Gynecology, 1991 - 1994- University of California (Irvine)Fellowship, Female Pelvic Medicine And Reconstructive Surgery (Obgyn), 1994
Union Memorial HospitalFellowship, Gynecologic Oncology, 1990- University of California (Irvine)Residency, Obstetrics and Gynecology, 1985 - 1989
University of California, Irvine, School of MedicineClass of 1985
Certifications & Licensure
MT State Medical License 2024 - 2026
MO State Medical License 1994 - 2025
CA State Medical License 1987 - 2024
KS State Medical License 1994 - 2024
MD State Medical License 1989 - 1990- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
- Super Doctor SuperDoctors.com
Clinical Trials
- Pharmacokinetic, Safety and Efficacy Study of Nanoparticle Paclitaxel in Patients With Peritoneal Cancers Start of enrollment: 2008 Jul 01
- Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2012 Jun 18
- Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian Cancer Start of enrollment: 2010 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 24 citationsCediranib in Combination with Olaparib in Patients without a Germline BRCA1/2 Mutation and with Recurrent Platinum-Resistant Ovarian Cancer: Phase IIb CONCERTO Trial.Jung-Min Lee, Richard G Moore, Sharad Ghamande, Min S Park, John P Diaz, Julia Chapman, James Kendrick, Brian M Slomovitz, Krishnansu S Tewari, Elizabeth S Lowe, Tsvet...> ;Clinical Cancer Research. 2022 Oct 3
- 8 citationsDisparities in ovarian cancer survival at the only NCI-designated cancer center in Kansas.Shariska Petersen, Parmida Shahiri, Andrea Jewell, Lori Spoozak, Julia Chapman, Sharon Fitzgerald-Wolff, Sue Min Lai, Dineo Khabele> ;American Journal of Surgery. 2021 Apr 1
- 45 citationsMicroRNA-205 promotes cell invasion by repressing TCF21 in human ovarian cancerJun Wei, Lahong Zhang, Jennifer Li, Shuguang Zhu, Minghui Tai, Clifford W. Mason, Julia Chapman, Evelyn A. Reynolds, Carl P. Weiner, Helen Zhou> ;Journal of Ovarian Research. 2017 May 5
- Join now to see all
Press Mentions
Benefits of High-Dose Vitamin C for Ovarian Cancer PatientsFebruary 6th, 2014
Professional Memberships
- Fellow
Hospital Affiliations
North Kansas City HospitalKansas City, Missouri
The University of Kansas HospitalKansas City, Kansas
AdventHealth Shawnee MissionOverland Park, Kansas- Overland Park Regional Medical CenterLenexa, Kansas
- Select Specialty Hospital-Western MissouriKansas City, Missouri
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
